Everest Medicines Ltd.(HK:1952)
HK$25.74+0.20 (+0.78%)
HK:1952
Everest Medicines Ltd. financials statements
HK$25.74
At close:+0.20 (+0.78%)
Want to see HK:1952 full AI Analyst Report?
Everest Medicines Ltd. (1952) Income Statement
5 Followers
Everest Medicines Ltd. Income Statement
Last quarter (Q2 2026), Everest Medicines Ltd.'s total revenue was ¥573.92M, an increase of 157.29% from the same quarter last year. In Q2, Everest Medicines Ltd.'s net income was ¥-2.97M. See Everest Medicines Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ¥ 1.71B | ¥ 706.68M | ¥ 125.93M | ¥ 12.79M | ¥ 54.00K | |
| ¥ 1.18B | ¥ 528.89M | ¥ 91.52M | ¥ 8.15M | ¥ 31.00K | |
| ¥ 1.57B | ¥ 1.65B | ¥ 1.02B | ¥ 264.95M | ¥ 1.03B | |
| Depreciation and Amortization | ¥ 156.52M | ¥ 133.62M | ¥ 76.78M | ¥ 42.77M | ¥ 31.12M |
| ¥ -187.37M | ¥ -646.59M | ¥ -744.63M | ¥ -198.91M | ¥ -972.78M | |
| ¥ -386.24M | ¥ -1.12B | ¥ -932.74M | ¥ -256.80M | ¥ -1.03B | |
| ¥ -212.12M | ¥ 75.67M | ¥ 88.28M | ¥ 9.53M | ¥ 17.61M | |
| ¥ -598.36M | ¥ -1.04B | ¥ -844.46M | ¥ -247.28M | ¥ -1.01B | |
| ¥ -297.77M | ¥ -1.04B | ¥ -844.46M | ¥ -247.28M | ¥ -1.01B | |
| Per Share Metrics | |||||
| Basic EPS | ¥ -0.89 | ¥ -3.24 | ¥ -2.70 | ¥ -0.83 | ¥ -3.44 |
| Diluted EPS | ¥ -0.89 | ¥ -3.24 | ¥ -2.70 | ¥ -0.83 | ¥ -3.44 |
| Weighted Average Shares Outstanding | 334.57M | 320.92M | 313.06M | 297.63M | 293.23M |
| Weighted Average Shares Outstanding (Diluted) | 336.46M | 320.92M | 313.06M | 297.63M | 293.27M |
Currency in CNY

